The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection
Open Access
- 6 September 2013
- journal article
- Published by Springer Nature in BMC Gastroenterology
- Vol. 13 (1) , 136
Abstract
There is a lack of consensus regarding the risk of postoperative hemorrhage in patients on antithrombotic therapy who undergo endoscopic submucosal dissection (ESD).Keywords
This publication has 30 references indexed in Scilit:
- Is Gastroduodenal Biopsy Safe in Patients Receiving Aspirin and Clopidogrel?Journal of Clinical Gastroenterology, 2011
- A randomized controlled trial of rebamipide plus rabeprazole for the healing of artificial ulcers after endoscopic submucosal dissectionJournal of Gastroenterology, 2011
- Risk factors for bleeding after endoscopic submucosal dissection for gastric lesionsWorld Journal of Gastroenterology, 2010
- Clinical trial: rebamipide promotes gastric ulcer healing by proton pump inhibitor after endoscopic submucosal dissection—a randomized controlled studyJournal of Gastroenterology, 2009
- Technical feasibility of endoscopic submucosal dissection for early gastric cancer in patients taking anti-coagulants or anti-platelet agentsDigestive and Liver Disease, 2009
- Risk factors for complications of endoscopic submucosal dissection in gastric tumors: analysis of 478 lesionsJournal of Gastroenterology, 2009
- Retrospective analysis on the management of anticoagulants and antiplatelet agents for scheduled endoscopyJournal of Gastroenterology, 2009
- Why does Japan have a high incidence of gastric cancer? Comparison of gastritis between UK and Japanese patientsGut, 2006
- Effect of oral omeprazole in reducing re‐bleeding in bleeding peptic ulcers: a prospective, double‐blind, randomized, clinical trialAlimentary Pharmacology & Therapeutics, 2003
- Risk of bleeding after endoscopic biopsy or polypectomy in patients taking aspirin or other NSAIDsGastrointestinal Endoscopy, 1994